Q4 met the street's expectations
07/02/25 -"GN’s Q4 results met market expectations. Healthy growth in the Hearing segment was counterbalanced by a weaker performance in Gaming & Consumer and Enterprise. For 2025, management expects ..."
Pages
65
Language
English
Published on
07/02/25
You may also be interested by these reports :
15/10/26
Dräger’s Q3 26 prelims were soft, with sales and EBIT 1.3% and 8.4% below our estimates. EBIT included €20.1m of customs refunds; excluding these, ...
13/10/26
Demant reported robust preliminary Q3 sales figures, driven by strong demand for its newly launched hearing aids. The 2026 guidance has been revised ...
09/10/26
Our target price has been revised downwards due to updated estimates following management’s decision to lower the upper end of its topline guidance ...
08/10/26
Our target price has increased due to a higher NAV and DCF, along with a 20% premium applied to our peer-based valuation metrics, excluding dividend ...